Predictors of physical restraint use in Canadian intensive care units View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-03-24

AUTHORS

Elena Luk, Barbara Sneyers, Louise Rose, Marc M Perreault, David R Williamson, Sangeeta Mehta, Deborah J Cook, Stephanie C Lapinsky, Lisa Burry

ABSTRACT

IntroductionPhysical restraint (PR) use in the intensive care unit (ICU) has been associated with higher rates of self-extubation and prolonged ICU length of stay. Our objectives were to describe patterns and predictors of PR use.MethodsWe conducted a secondary analysis of a prospective observational study of analgosedation, antipsychotic, neuromuscular blocker, and PR practices in 51 Canadian ICUs. Data were collected prospectively for all mechanically ventilated adults admitted during a two-week period. We tested for patient, treatment, and hospital characteristics that were associated with PR use and number of days of use, using logistic and Poisson regression respectively.ResultsPR was used on 374 out of 711 (53%) patients, for a mean number of 4.1 (standard deviation (SD) 4.0) days. Treatment characteristics associated with PR were higher daily benzodiazepine dose (odds ratio (OR) 1.05, 95% confidence interval (CI) 1.00 to 1.11), higher daily opioid dose (OR 1.04, 95% CI 1.01 to 1.06), antipsychotic drugs (OR 3.09, 95% CI 1.74 to 5.48), agitation (Sedation-Agitation Scale (SAS) >4) (OR 3.73, 95% CI 1.50 to 9.29), and sedation administration method (continuous and bolus versus bolus only) (OR 3.09, 95% CI 1.74 to 5.48). Hospital characteristics associated with PR indicated patients were less likely to be restrained in ICUs from university-affiliated hospitals (OR 0.32, 95% CI 0.17 to 0.61). Mainly treatment characteristics were associated with more days of PR, including: higher daily benzodiazepine dose (incidence rate ratio (IRR) 1.07, 95% CI 1.01 to 1.13), daily sedation interruption (IRR 3.44, 95% CI 1.48 to 8.10), antipsychotic drugs (IRR 15.67, 95% CI 6.62 to 37.12), SAS <3 (IRR 2.62, 95% CI 1.08 to 6.35), and any adverse event including accidental device removal (IRR 8.27, 95% CI 2.07 to 33.08). Patient characteristics (age, gender, Acute Physiology and Chronic Health Evaluation II score, admission category, prior substance abuse, prior psychotropic medication, pre-existing psychiatric condition or dementia) were not associated with PR use or number of days used.ConclusionsPR was used in half of the patients in these 51 ICUs. Treatment characteristics predominantly predicted PR use, as opposed to patient or hospital/ICU characteristics. Use of sedative, analgesic, and antipsychotic drugs, agitation, heavy sedation, and occurrence of an adverse event predicted PR use or number of days used. More... »

PAGES

r46

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/cc13789

DOI

http://dx.doi.org/10.1186/cc13789

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052154031

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24661688


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Canada", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Forecasting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intensive Care Units", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Restraint, Physical", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Rm 276, M5T 1P8, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Rm 276, M5T 1P8, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luk", 
        "givenName": "Elena", 
        "id": "sg:person.0635102307.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635102307.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Avenue Hippocrate, 10, Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.7942.8", 
          "name": [
            "Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Avenue Hippocrate, 10, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sneyers", 
        "givenName": "Barbara", 
        "id": "sg:person.0727365706.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727365706.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Rm 276, M5T 1P8, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Rm 276, M5T 1P8, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rose", 
        "givenName": "Louise", 
        "id": "sg:person.0740410436.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740410436.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de pharmacie, Universit\u00e9 de Montr\u00e9al, CP 6128 succursale centre-ville, H3C 3J7, Montr\u00e9al, QC, Canada", 
          "id": "http://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Facult\u00e9 de pharmacie, Universit\u00e9 de Montr\u00e9al, CP 6128 succursale centre-ville, H3C 3J7, Montr\u00e9al, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perreault", 
        "givenName": "Marc M", 
        "id": "sg:person.0772060673.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772060673.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de pharmacie, Universit\u00e9 de Montr\u00e9al, CP 6128 succursale centre-ville, H3C 3J7, Montr\u00e9al, QC, Canada", 
          "id": "http://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Facult\u00e9 de pharmacie, Universit\u00e9 de Montr\u00e9al, CP 6128 succursale centre-ville, H3C 3J7, Montr\u00e9al, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Williamson", 
        "givenName": "David R", 
        "id": "sg:person.01365714423.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365714423.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mount Sinai Hospital, 600 University Avenue, ON, Toronto, M5G 1X5, Canada", 
          "id": "http://www.grid.ac/institutes/grid.416166.2", 
          "name": [
            "Mount Sinai Hospital, 600 University Avenue, ON, Toronto, M5G 1X5, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehta", 
        "givenName": "Sangeeta", 
        "id": "sg:person.01244447225.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244447225.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Medicine, Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Center, 1200 Main Street West, L8N 3Z5, Hamilton, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Departments of Medicine, Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Center, 1200 Main Street West, L8N 3Z5, Hamilton, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cook", 
        "givenName": "Deborah J", 
        "id": "sg:person.01372124736.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372124736.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Faculty of Medicine, University of Toronto, 1 King\u2019s College Circle, Medical Sciences Building, M5S 1A8, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Faculty of Medicine, University of Toronto, 1 King\u2019s College Circle, Medical Sciences Building, M5S 1A8, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lapinsky", 
        "givenName": "Stephanie C", 
        "id": "sg:person.01142132022.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142132022.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mount Sinai Hospital, 600 University Avenue, ON, Toronto, M5G 1X5, Canada", 
          "id": "http://www.grid.ac/institutes/grid.416166.2", 
          "name": [
            "Mount Sinai Hospital, 600 University Avenue, ON, Toronto, M5G 1X5, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burry", 
        "givenName": "Lisa", 
        "id": "sg:person.01362024562.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362024562.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/cc7892", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006217445", 
          "https://doi.org/10.1186/cc7892"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-012-2715-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002844089", 
          "https://doi.org/10.1007/s00134-012-2715-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-007-0600-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014257515", 
          "https://doi.org/10.1007/s00134-007-0600-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-03-24", 
    "datePublishedReg": "2014-03-24", 
    "description": "IntroductionPhysical restraint (PR) use in the intensive care unit (ICU) has been associated with higher rates of self-extubation and prolonged ICU length of stay. Our objectives were to describe patterns and predictors of PR use.MethodsWe conducted a secondary analysis of a prospective observational study of analgosedation, antipsychotic, neuromuscular blocker, and PR practices in 51 Canadian ICUs. Data were collected prospectively for all mechanically ventilated adults admitted during a two-week period. We tested for patient, treatment, and hospital characteristics that were associated with PR use and number of days of use, using logistic and Poisson regression respectively.ResultsPR was used on 374 out of 711 (53%) patients, for a mean number of 4.1 (standard deviation (SD) 4.0) days. Treatment characteristics associated with PR were higher daily benzodiazepine dose (odds ratio (OR) 1.05, 95% confidence interval (CI) 1.00 to 1.11), higher daily opioid dose (OR 1.04, 95% CI 1.01 to 1.06), antipsychotic drugs (OR 3.09, 95% CI 1.74 to 5.48), agitation (Sedation-Agitation Scale (SAS) >4) (OR 3.73, 95% CI 1.50 to 9.29), and sedation administration method (continuous and bolus versus bolus only) (OR 3.09, 95% CI 1.74 to 5.48). Hospital characteristics associated with PR indicated patients were less likely to be restrained in ICUs from university-affiliated hospitals (OR 0.32, 95% CI 0.17 to 0.61). Mainly treatment characteristics were associated with more days of PR, including: higher daily benzodiazepine dose (incidence rate ratio (IRR) 1.07, 95% CI 1.01 to 1.13), daily sedation interruption (IRR 3.44, 95% CI 1.48 to 8.10), antipsychotic drugs (IRR 15.67, 95% CI 6.62 to 37.12), SAS <3 (IRR 2.62, 95% CI 1.08 to 6.35), and any adverse event including accidental device removal (IRR 8.27, 95% CI 2.07 to 33.08). Patient characteristics (age, gender, Acute Physiology and Chronic Health Evaluation II score, admission category, prior substance abuse, prior psychotropic medication, pre-existing psychiatric condition or dementia) were not associated with PR use or number of days used.ConclusionsPR was used in half of the patients in these 51 ICUs. Treatment characteristics predominantly predicted PR use, as opposed to patient or hospital/ICU characteristics. Use of sedative, analgesic, and antipsychotic drugs, agitation, heavy sedation, and occurrence of an adverse event predicted PR use or number of days used.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/cc13789", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1117766", 
        "issn": [
          "1364-8535", 
          "1466-609X"
        ], 
        "name": "Critical Care", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "intensive care unit", 
      "Canadian intensive care units", 
      "PR use", 
      "treatment characteristics", 
      "antipsychotic drugs", 
      "adverse events", 
      "care unit", 
      "hospital characteristics", 
      "restraint use", 
      "number of days", 
      "higher daily opioid dose", 
      "prolonged ICU length", 
      "daily opioid dose", 
      "daily sedation interruption", 
      "accidental device removal", 
      "prospective observational study", 
      "university-affiliated hospital", 
      "physical restraint use", 
      "opioid dose", 
      "sedation interruption", 
      "ICU length", 
      "ventilated adults", 
      "patient characteristics", 
      "ICU characteristics", 
      "neuromuscular blockers", 
      "heavy sedation", 
      "observational study", 
      "device removal", 
      "patients", 
      "Poisson regression", 
      "secondary analysis", 
      "administration methods", 
      "more days", 
      "mean number", 
      "two-week period", 
      "drugs", 
      "high rate", 
      "benzodiazepines", 
      "days", 
      "predictors", 
      "ConclusionsPR", 
      "analgosedation", 
      "sedation", 
      "stay", 
      "blockers", 
      "hospital", 
      "MethodsWe", 
      "dose", 
      "adults", 
      "treatment", 
      "agitation", 
      "use", 
      "events", 
      "regression", 
      "PR", 
      "number", 
      "interruption", 
      "period", 
      "half", 
      "study", 
      "characteristics", 
      "units", 
      "occurrence", 
      "rate", 
      "SAS", 
      "objective", 
      "practice", 
      "patterns", 
      "data", 
      "removal", 
      "analysis", 
      "length", 
      "method", 
      "PR practice"
    ], 
    "name": "Predictors of physical restraint use in Canadian intensive care units", 
    "pagination": "r46", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052154031"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/cc13789"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24661688"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/cc13789", 
      "https://app.dimensions.ai/details/publication/pub.1052154031"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_628.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/cc13789"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/cc13789'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/cc13789'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/cc13789'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/cc13789'


 

This table displays all metadata directly associated to this object as RDF triples.

261 TRIPLES      21 PREDICATES      113 URIs      102 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/cc13789 schema:about N220d051eee4d4330a1a11792af267b03
2 N2cb1abba2b5a46ee92d8ab239cea3f5a
3 N2ea403d5b4764c7fb647b845fd997a39
4 N47c125c776a24790b964d5a267826827
5 N47c6be3e6d3144c1a1cbc85d95362ff3
6 N50216ad978d44e5da1ee6fbfe33ae8ec
7 N51fef491296a418e901a013d3f3a3632
8 N6cb9ce20cc4747fab7c6b1f08a16b528
9 N7a16478ab6f04834a965a567de280f6d
10 N9708db0975db4f6993f04c844a4d76d7
11 Nd6a5ac163923495cb8c4962f1ab9e16d
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author Nfb1651430473439698590aceeaa18159
15 schema:citation sg:pub.10.1007/s00134-007-0600-8
16 sg:pub.10.1007/s00134-012-2715-9
17 sg:pub.10.1186/cc7892
18 schema:datePublished 2014-03-24
19 schema:datePublishedReg 2014-03-24
20 schema:description IntroductionPhysical restraint (PR) use in the intensive care unit (ICU) has been associated with higher rates of self-extubation and prolonged ICU length of stay. Our objectives were to describe patterns and predictors of PR use.MethodsWe conducted a secondary analysis of a prospective observational study of analgosedation, antipsychotic, neuromuscular blocker, and PR practices in 51 Canadian ICUs. Data were collected prospectively for all mechanically ventilated adults admitted during a two-week period. We tested for patient, treatment, and hospital characteristics that were associated with PR use and number of days of use, using logistic and Poisson regression respectively.ResultsPR was used on 374 out of 711 (53%) patients, for a mean number of 4.1 (standard deviation (SD) 4.0) days. Treatment characteristics associated with PR were higher daily benzodiazepine dose (odds ratio (OR) 1.05, 95% confidence interval (CI) 1.00 to 1.11), higher daily opioid dose (OR 1.04, 95% CI 1.01 to 1.06), antipsychotic drugs (OR 3.09, 95% CI 1.74 to 5.48), agitation (Sedation-Agitation Scale (SAS) >4) (OR 3.73, 95% CI 1.50 to 9.29), and sedation administration method (continuous and bolus versus bolus only) (OR 3.09, 95% CI 1.74 to 5.48). Hospital characteristics associated with PR indicated patients were less likely to be restrained in ICUs from university-affiliated hospitals (OR 0.32, 95% CI 0.17 to 0.61). Mainly treatment characteristics were associated with more days of PR, including: higher daily benzodiazepine dose (incidence rate ratio (IRR) 1.07, 95% CI 1.01 to 1.13), daily sedation interruption (IRR 3.44, 95% CI 1.48 to 8.10), antipsychotic drugs (IRR 15.67, 95% CI 6.62 to 37.12), SAS <3 (IRR 2.62, 95% CI 1.08 to 6.35), and any adverse event including accidental device removal (IRR 8.27, 95% CI 2.07 to 33.08). Patient characteristics (age, gender, Acute Physiology and Chronic Health Evaluation II score, admission category, prior substance abuse, prior psychotropic medication, pre-existing psychiatric condition or dementia) were not associated with PR use or number of days used.ConclusionsPR was used in half of the patients in these 51 ICUs. Treatment characteristics predominantly predicted PR use, as opposed to patient or hospital/ICU characteristics. Use of sedative, analgesic, and antipsychotic drugs, agitation, heavy sedation, and occurrence of an adverse event predicted PR use or number of days used.
21 schema:genre article
22 schema:isAccessibleForFree true
23 schema:isPartOf N51e9eb1bac624e3aa4d4aee3b016ddf7
24 Ncc81eb00802c4b4cbcaa273eef5a8fba
25 sg:journal.1117766
26 schema:keywords Canadian intensive care units
27 ConclusionsPR
28 ICU characteristics
29 ICU length
30 MethodsWe
31 PR
32 PR practice
33 PR use
34 Poisson regression
35 SAS
36 accidental device removal
37 administration methods
38 adults
39 adverse events
40 agitation
41 analgosedation
42 analysis
43 antipsychotic drugs
44 benzodiazepines
45 blockers
46 care unit
47 characteristics
48 daily opioid dose
49 daily sedation interruption
50 data
51 days
52 device removal
53 dose
54 drugs
55 events
56 half
57 heavy sedation
58 high rate
59 higher daily opioid dose
60 hospital
61 hospital characteristics
62 intensive care unit
63 interruption
64 length
65 mean number
66 method
67 more days
68 neuromuscular blockers
69 number
70 number of days
71 objective
72 observational study
73 occurrence
74 opioid dose
75 patient characteristics
76 patients
77 patterns
78 period
79 physical restraint use
80 practice
81 predictors
82 prolonged ICU length
83 prospective observational study
84 rate
85 regression
86 removal
87 restraint use
88 secondary analysis
89 sedation
90 sedation interruption
91 stay
92 study
93 treatment
94 treatment characteristics
95 two-week period
96 units
97 university-affiliated hospital
98 use
99 ventilated adults
100 schema:name Predictors of physical restraint use in Canadian intensive care units
101 schema:pagination r46
102 schema:productId N3d2dd8e72d3546e8bb5d4fd2e0b4ce2e
103 Ne54c8fe423d04c63a7b87e2cd8d68dbb
104 Nf33819a5430143d28392bd27272beedb
105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052154031
106 https://doi.org/10.1186/cc13789
107 schema:sdDatePublished 2022-08-04T17:02
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher Nd2152cd2eeec44d5b0cffd5573bb0dba
110 schema:url https://doi.org/10.1186/cc13789
111 sgo:license sg:explorer/license/
112 sgo:sdDataset articles
113 rdf:type schema:ScholarlyArticle
114 N151a277bbc3c49ebbdb32d2c513650a5 rdf:first sg:person.01362024562.00
115 rdf:rest rdf:nil
116 N220d051eee4d4330a1a11792af267b03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Middle Aged
118 rdf:type schema:DefinedTerm
119 N2cb1abba2b5a46ee92d8ab239cea3f5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Adult
121 rdf:type schema:DefinedTerm
122 N2ea403d5b4764c7fb647b845fd997a39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Prospective Studies
124 rdf:type schema:DefinedTerm
125 N3ac7909a9243440b9ebfef1eb9975c76 rdf:first sg:person.01142132022.58
126 rdf:rest N151a277bbc3c49ebbdb32d2c513650a5
127 N3d2dd8e72d3546e8bb5d4fd2e0b4ce2e schema:name doi
128 schema:value 10.1186/cc13789
129 rdf:type schema:PropertyValue
130 N47c125c776a24790b964d5a267826827 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Humans
132 rdf:type schema:DefinedTerm
133 N47c6be3e6d3144c1a1cbc85d95362ff3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Restraint, Physical
135 rdf:type schema:DefinedTerm
136 N50216ad978d44e5da1ee6fbfe33ae8ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Canada
138 rdf:type schema:DefinedTerm
139 N51e9eb1bac624e3aa4d4aee3b016ddf7 schema:issueNumber 2
140 rdf:type schema:PublicationIssue
141 N51fef491296a418e901a013d3f3a3632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Forecasting
143 rdf:type schema:DefinedTerm
144 N6cb9ce20cc4747fab7c6b1f08a16b528 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Aged
146 rdf:type schema:DefinedTerm
147 N7a16478ab6f04834a965a567de280f6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Male
149 rdf:type schema:DefinedTerm
150 N7e1d39f94f5343c6bc12c684da0f9c27 rdf:first sg:person.0740410436.86
151 rdf:rest Ne012f99c6942489c942e2bfe8990d535
152 N9708db0975db4f6993f04c844a4d76d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Intensive Care Units
154 rdf:type schema:DefinedTerm
155 N9b654932c2e844a3a41d59916c69a99a rdf:first sg:person.0727365706.39
156 rdf:rest N7e1d39f94f5343c6bc12c684da0f9c27
157 Nb74a83c52e08464d9bc843803957c066 rdf:first sg:person.01244447225.31
158 rdf:rest Ndde059aa795c4b84ad063c1b8b715cde
159 Nc2463a4f2adc4c3490d262259532c88e rdf:first sg:person.01365714423.46
160 rdf:rest Nb74a83c52e08464d9bc843803957c066
161 Ncc81eb00802c4b4cbcaa273eef5a8fba schema:volumeNumber 18
162 rdf:type schema:PublicationVolume
163 Nd2152cd2eeec44d5b0cffd5573bb0dba schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Nd6a5ac163923495cb8c4962f1ab9e16d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Female
167 rdf:type schema:DefinedTerm
168 Ndde059aa795c4b84ad063c1b8b715cde rdf:first sg:person.01372124736.59
169 rdf:rest N3ac7909a9243440b9ebfef1eb9975c76
170 Ne012f99c6942489c942e2bfe8990d535 rdf:first sg:person.0772060673.93
171 rdf:rest Nc2463a4f2adc4c3490d262259532c88e
172 Ne54c8fe423d04c63a7b87e2cd8d68dbb schema:name dimensions_id
173 schema:value pub.1052154031
174 rdf:type schema:PropertyValue
175 Nf33819a5430143d28392bd27272beedb schema:name pubmed_id
176 schema:value 24661688
177 rdf:type schema:PropertyValue
178 Nfb1651430473439698590aceeaa18159 rdf:first sg:person.0635102307.79
179 rdf:rest N9b654932c2e844a3a41d59916c69a99a
180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
181 schema:name Medical and Health Sciences
182 rdf:type schema:DefinedTerm
183 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
184 schema:name Clinical Sciences
185 rdf:type schema:DefinedTerm
186 sg:journal.1117766 schema:issn 1364-8535
187 1466-609X
188 schema:name Critical Care
189 schema:publisher Springer Nature
190 rdf:type schema:Periodical
191 sg:person.01142132022.58 schema:affiliation grid-institutes:grid.17063.33
192 schema:familyName Lapinsky
193 schema:givenName Stephanie C
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142132022.58
195 rdf:type schema:Person
196 sg:person.01244447225.31 schema:affiliation grid-institutes:grid.416166.2
197 schema:familyName Mehta
198 schema:givenName Sangeeta
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244447225.31
200 rdf:type schema:Person
201 sg:person.01362024562.00 schema:affiliation grid-institutes:grid.416166.2
202 schema:familyName Burry
203 schema:givenName Lisa
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362024562.00
205 rdf:type schema:Person
206 sg:person.01365714423.46 schema:affiliation grid-institutes:grid.14848.31
207 schema:familyName Williamson
208 schema:givenName David R
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365714423.46
210 rdf:type schema:Person
211 sg:person.01372124736.59 schema:affiliation grid-institutes:grid.25073.33
212 schema:familyName Cook
213 schema:givenName Deborah J
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372124736.59
215 rdf:type schema:Person
216 sg:person.0635102307.79 schema:affiliation grid-institutes:grid.17063.33
217 schema:familyName Luk
218 schema:givenName Elena
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635102307.79
220 rdf:type schema:Person
221 sg:person.0727365706.39 schema:affiliation grid-institutes:grid.7942.8
222 schema:familyName Sneyers
223 schema:givenName Barbara
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727365706.39
225 rdf:type schema:Person
226 sg:person.0740410436.86 schema:affiliation grid-institutes:grid.17063.33
227 schema:familyName Rose
228 schema:givenName Louise
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740410436.86
230 rdf:type schema:Person
231 sg:person.0772060673.93 schema:affiliation grid-institutes:grid.14848.31
232 schema:familyName Perreault
233 schema:givenName Marc M
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772060673.93
235 rdf:type schema:Person
236 sg:pub.10.1007/s00134-007-0600-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014257515
237 https://doi.org/10.1007/s00134-007-0600-8
238 rdf:type schema:CreativeWork
239 sg:pub.10.1007/s00134-012-2715-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002844089
240 https://doi.org/10.1007/s00134-012-2715-9
241 rdf:type schema:CreativeWork
242 sg:pub.10.1186/cc7892 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006217445
243 https://doi.org/10.1186/cc7892
244 rdf:type schema:CreativeWork
245 grid-institutes:grid.14848.31 schema:alternateName Faculté de pharmacie, Université de Montréal, CP 6128 succursale centre-ville, H3C 3J7, Montréal, QC, Canada
246 schema:name Faculté de pharmacie, Université de Montréal, CP 6128 succursale centre-ville, H3C 3J7, Montréal, QC, Canada
247 rdf:type schema:Organization
248 grid-institutes:grid.17063.33 schema:alternateName Faculty of Medicine, University of Toronto, 1 King’s College Circle, Medical Sciences Building, M5S 1A8, Toronto, ON, Canada
249 Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Rm 276, M5T 1P8, Toronto, ON, Canada
250 schema:name Faculty of Medicine, University of Toronto, 1 King’s College Circle, Medical Sciences Building, M5S 1A8, Toronto, ON, Canada
251 Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 155 College Street, Rm 276, M5T 1P8, Toronto, ON, Canada
252 rdf:type schema:Organization
253 grid-institutes:grid.25073.33 schema:alternateName Departments of Medicine, Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Center, 1200 Main Street West, L8N 3Z5, Hamilton, ON, Canada
254 schema:name Departments of Medicine, Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Center, 1200 Main Street West, L8N 3Z5, Hamilton, ON, Canada
255 rdf:type schema:Organization
256 grid-institutes:grid.416166.2 schema:alternateName Mount Sinai Hospital, 600 University Avenue, ON, Toronto, M5G 1X5, Canada
257 schema:name Mount Sinai Hospital, 600 University Avenue, ON, Toronto, M5G 1X5, Canada
258 rdf:type schema:Organization
259 grid-institutes:grid.7942.8 schema:alternateName Louvain Drug Research Institute, Université catholique de Louvain, Avenue Hippocrate, 10, Brussels, Belgium
260 schema:name Louvain Drug Research Institute, Université catholique de Louvain, Avenue Hippocrate, 10, Brussels, Belgium
261 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...